Clinical Trial Update: Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial using multiparametric MRI to evaluate intraprostatic tumor responses and androgen resistance patterns in newly diagnosed prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-02